NCT07244042 Effects of Modified CIMT With and Without PNF
| NCT ID | NCT07244042 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Pediatric Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-10-27 |
| Primary Completion | 2026-01-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-10-27 with a primary completion date of 2026-01-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial investigates the effects of modified CIMT with and without the addition of PNF techniques on upper extremity function in pediatric stroke patients, aiming to determine whether combining these approaches yields superior motor recovery.This study will be conducted as a randomized clinical trial over an intervention period of six-week. 20 pediatric stroke patients with upper extremity impairments will be randomly assigned to two groups: one receiving modified CIMT alone and the other receiving modified CIMT combined with PNF techniques. Pre- and post-intervention assessments will be conducted using standardized measures, such as Pediatric Motor Activity Log(PMAL) for upper extremity function, Modified Ashworth Scale(MAS) and Manual Ability Classification System(MACS). Muscle tone and physical activity status will also be evaluated. Data will be entered and analyzed in SPSS V-26.0 to compare improvements in motor function between the two groups, with statistical significance assessed to determine the efficacy of each intervention
Eligibility Criteria
Inclusion Criteria: * Paeds Patients with confirmed diagnosis of Stroke * Children between age 5 to 13 years * Modified Ashworth Scale spasticity level 1 and 2. * Patients having Manual Ability Classification System Score between 3 to 6. * GMFCS level 1 and 2 * Patient having in affected upper extremity at least 20◦ of active wrist extension starting from the full flexion, 10◦ of active extension or abduction in the thumb, and 10◦ of active extension in the metacarpophalangeal and interphalangeal joints of the other fingers Exclusion Criteria: * Patients with epilepsy or seizure disorder * Patients with history of botulinum toxin injection, cognitive impairment, fracture and any surgical procedure in upper extremity
Contact & Investigator
Maida Shabbir, MS-PT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07244042 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 13 Years, studying Pediatric Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07244042 currently recruiting?
Yes, NCT07244042 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07244042 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07244042 clinical trial?
NCT07244042 is sponsored by Riphah International University. The principal investigator is Maida Shabbir, MS-PT at Riphah International University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.